Inclusion Criteria:

- Histologically confirmed liver metastases

- Largest burden of disease should be hepatic if there's extrahepatic disease exists

- Tumour should be medically inoperable

- Patient have a life expectancy of at least 3 months and a KPS performance status of
at least 60%.

- Patient should be 18 years of age or older

- Patient should have adequate organ function

- Patient have Creatinine ≤ 2 times upper limit of normal range

- Patient recovered from the effects of prior therapy

- Patient (or person representing the patient) should be able to give informed consent

- Patient have Child's A score (5 or 6) score

- For women of childbearing age, birth control is being used and the pregnancy test is
negative

Exclusion Criteria:

- No major surgery in the past 4 weeks.

- No previous use of sorafenib previously.

- Patient should not have or is receiving systemic therapy or investigational agents
within 2 weeks of radiotherapy

- No previous upper abdominal radiation therapy to the liver.

- No serious medical conditions that may be aggravated by treatment, including but not
limited to: myocardial infarction within 6 months, congestive cardiac failure,
unstable angina, active cardiomyopathy, unstable ventricular arrhythmia, uncontrolled
hypertension, uncontrolled psychotic disorders,serious infections, active peptic
ulcer disease, active liver disease or previous stroke.

- Patients who are infected with human immunodeficiency virus (HIV), should not be
receiving combination anti-retroviral therapy

- No clinically significant liver failure (i.e. encephalopathy or ascites found
clinically).

- No thrombolytic therapy within 4 weeks or are they receiving other anticoagulant
therapy.

- No underlying cirrhosis with Child's B or C score.

- No history of uncontrolled, life threatening malignancy within the past 6 months.

- Patient should not have a variceal bleed or other gastrointestinal bleed in the past
2 months.

- No brain metastases

- Patient should not be pregnant.

- Patients on Rifampin, St. John's Wort, Phenytoin, Carbamazepine, Phenobarbital, or
Chronic use (more than 4 weeks) of dexamethasone